Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Otolaryngology
Volume 2014, Article ID 139386, 5 pages
http://dx.doi.org/10.1155/2014/139386
Case Report

A Rare Case of Splenic Marginal Zone B-Cell Lymphoma Mimicking Relapsing Polychondritis of the Ear

1OSF Saint Anthony Health System, Department of Surgery, University of Illinois College of Medicine at Rockford, Rockford, IL 61103, USA
2OSF Specialty Clinic, 698 Featherstone Road, Guilford Square, Rockford, IL 61107, USA
3OSF Health System, Section of Otolaryngology, Head and Neck Surgery, Department of General Surgery, University of Illinois College of Medicine at Rockford, Rockford, IL 61107, USA
4Department of Biomedical Science, University of Illinois College of Medicine at Rockford, Rockford, IL 61101, USA

Received 1 September 2014; Revised 4 November 2014; Accepted 10 November 2014; Published 2 December 2014

Academic Editor: Rong-San Jiang

Copyright © 2014 Gary J. Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. S. Luthra, “Relapsing polychondritis,” in Rheumatology, J. H. Klippel and P. A. Dieppe, Eds., vol. 27, pp. 21–24, Harcourt Publishers Limited, 2000. View at Google Scholar
  2. T. Yanagi, T. Matsumura, R. Kamekura, N. Sasaki, and S. Hashino, “Relapsing polychondritis and malignant lymphoma: is polychondritis paraneoplastic?” Archives of Dermatology, vol. 143, no. 1, pp. 89–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. L. P. McAdam, M. A. O'Hanlan, R. Bluestone, and C. M. Pearson, “Relapsing polychondritis: prospective study of 23 patients and a review of the literature,” Medicine (Baltimore), vol. 55, pp. 193–215, 1976. View at Publisher · View at Google Scholar
  4. J. M. Damiani and H. L. Levine, “Relapsing polychondritis—report of ten cases,” Laryngoscope, vol. 89, no. 6, part 1, pp. 929–946, 1979. View at Google Scholar · View at Scopus
  5. L. Liu, H. Wang, Y. Chen, L. Rustveld, G. Liu, and X. L. Du, “Splenic marginal zone lymphoma: a population-based study on the 2001–2008 incidence and survival in the United States,” Leukemia and Lymphoma, vol. 54, no. 7, pp. 1380–1386, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Audouin, A. Le Tourneau, T. Molina et al., “Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes,” British Journal of Haematology, vol. 122, no. 3, pp. 404–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Franco, A. M. Florena, and E. Iannitto, “Splenic marginal zone lymphoma,” Blood, vol. 101, no. 7, pp. 2464–2472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. I. Chacón, M. Mollejo, E. Muñoz et al., “Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients,” Blood, vol. 100, no. 5, pp. 1648–1654, 2002. View at Google Scholar · View at Scopus
  9. S. B. Miller, C. J. Donlan, and S. B. Roth, “Hodgkin's disease presenting as relapsing polychondritis. A previously undescribed association,” Arthritis and Rheumatism, vol. 17, no. 5, pp. 598–602, 1974. View at Publisher · View at Google Scholar · View at Scopus
  10. H. R. A. Fransen, F. A. Ramon, A. M. A. De Schepper, L. H. L. De Beuckeleer, J. Bal, and G. Goovaerts, “Chondrosarcoma in a patient with relapsing polychondritis,” Skeletal Radiology, vol. 24, no. 6, pp. 477–480, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Bochtler, M. Hensel, H.-M. Lorenz, A. D. Ho, and U. Mahlknecht, “Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: a report on one treatment for the combined manifestation of two diseases,” Rheumatology, vol. 44, no. 9, p. 1199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Castrejon, M. Ibanez, E. Vicente, J. L. Steegmann, and S. Castaneda Sanz, “Relapsing polychondritis associated with a lymphoplasmocytic lymphoma and erythema nodosum,” Reumatologia Clinica, vol. 3, no. 1, pp. 45–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. Lichauco, S. Lauer, H. H. Shigemitsu et al., “Orbital mucosa-associated lymphoid tissue (MALT)-type lymphoma in a patient with relapsing polychondritis,” Arthritis & Rheumatology, vol. 44, no. 7, pp. 1713–1715, 2001. View at Google Scholar
  14. C. Thieblemont, P. Felman, F. Berger et al., “Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients,” Clinical Lymphoma, vol. 3, no. 1, pp. 41–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Lenglet, C. Traullé, N. Mounier et al., “Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment,” Leukemia & Lymphoma, vol. 55, no. 8, pp. 1854–1860, 2014. View at Publisher · View at Google Scholar
  16. A. J. Olszewski, “Survival outcomes with and without splenectomy in splenic marginal zone lymphoma,” The American Journal of Hematology, vol. 87, no. 11, pp. E119–E122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Milosevic, M. Todorovic, B. Balint et al., “Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma,” World Journal of Gastroenterology, vol. 15, no. 32, pp. 4009–4015, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Cervetti, S. Galimberti, M. Pelosini, F. Ghio, N. Cecconi, and M. Petrini, “Significant efficacy of 2-chlorodeoxyadenosine± rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up,” Annals of Oncology, vol. 24, no. 9, Article ID mdt181, pp. 2434–2438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Else, A. Marín-Niebla, F. de la Cruz et al., “Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma,” British Journal of Haematology, vol. 159, no. 3, pp. 322–328, 2012. View at Publisher · View at Google Scholar · View at Scopus